MIRA Pharmaceuticals Expands Ketamir-2 Development with Topical Treatment for Localized Neuropathic and Inflammatory Pain
MIRA Pharmaceuticals, Inc. (NASDAQ:MIRA), a clinical-stage pharmaceutical company focused on developing therapies for neurological and neuropsychiatric disorders, today announced the successful ...
China’s $2B Blockbuster ‘Ne Zha 2’ to Release Across Europe
Already the highest-grossing animated film in movie history, the film will soon launch in the U.K., Germany, France, Spain ...